Patients increasingly bypass insurance to pay cash for GLP-1 prescriptions, pharmacists say
The trend reflects the rapidly evolving GLP-1 marketplace.
The trend reflects the rapidly evolving GLP-1 marketplace.
The new offering includes DirectAccess, a direct-to-consumer option that provides eligible members access to GLP-1 medications for weight management outside the traditional pharmacy benefit.
The program includes upfront GLP-1 costs and an option for on-demand care—increasing patient access and choice for weight loss care.
MOBI is addressing a practical at-home need.
The Consumer Collective's national study of 500 U.S. adults shows GLP-1 users spend $449 a month on fitness, against $120 for non-users.
Study shows sustained Zepbound use in older adults with obesity lowers costs, reinforcing the potential value of the Medicare GLP-1 Bridge program.
Inaugural ratings evaluate leading online GLP-1 platforms to help consumers make informed decisions in the fast-growing weight management market.
Offers all FDA approved GLP-1s, whether through insurance or cash-pay options.
The GLP-1 medications currently available through the program include Foundayo, Wegovy in both injectable and tablet forms, and Zepbound KwikPen.
Alliance supports education, stigma reduction, and access to multidisciplinary care for eligible Canadians seeking support for obesity and long-term weight management.
Kroger Health dietitians share practical guidance for patients navigating weight-management treatment as part of Kroger's new GLP-1 Complete Support Program.
Aims to help patients find affordable GLP-1 medication options.
The program follows the recent launch of Medicare’s new GLP-1 Bridge program.
eligible Medicare patients living with obesity can access Wegovy® (semaglutide) injection and pill for a $50 monthly copay
New initiative expands access to trusted information, pharmacy support, and healthcare navigation resources for Medicare beneficiaries as Medicare GLP-1 Bridge program launches.
Eligible Medicare patients can access support through a new $50 monthly copay, including one-on-one pharmacist guidance and over-the-counter products to help manage common side effects.